Chemistry Reference
In-Depth Information
68. Wang, L. S.; Zhou, J.; Shao, X. M.; Tang, X. C. Huperzine A attenuates cognitive deficits
and brain injury in neonatal rats after hypoxia-ischemia. Brain Res., 2002, 949(1-2):
162-170.
69. Grunwald, J.; Raveh, L.; Doctor, B. P.; Ashani, Y. Huperzine A as a pretreatment
candidate drug against nerve agent toxicity. Life Sci., 1994, 54: 991-997.
70. Gordon, R. K.; Nigam, S. V.; Weitz, J. A.; Dave, J. R.; Doctor, B. P.; Ved, H. S. The
NMDA receptor ion channel: a site for binding of Huperzine A. J. Appl. Toxicol., 2001,
21(Suppl 1): S47-S51.
71. Sattler, R.; Tymianski, M. Molecular mechanisms of calcium-dependent excitotoxicity.
J. Mol. Med., 2000, 78(1): 3-13.
72. Choi, D. W. Calcium and excitotoxic neuronal injury. Ann. N Y Acad. Sci., 1994, 747:
162-171.
73. Wang, X. D.; Zhang, J. M.; Yang, H. H.; Hu, G. Y. Modulation of NMDA receptor by
huperzine A in rat cerebral cortex. Acta Pharmacol. Sin., 1999, 20: 31-35.
74. Vajda, F. J. Neuroprotection and neurodegenerative disease. J. Clin. Neurosci., 2002,
9(1): 4-8.
75. Perry, E. K.; Tomlinson, B. E.; Blessed, G.; Bergman, K.; Gibson, P. H.; Perry, R. H.
Correlation of cholinergic abnormalities with senile plaques and mental scores. Br. Med.
J., 1978, 2: 1457-1459.
76. Selkoe, D. J.; Abraham, C. R.; Podlisny, M. B.; Duffy, L. K. Isolation of low-molecular-
weight proteins from amyloid plaque fibers in Alzheimer's disease. J. Neurochem., 1986,
46(6): 1820-1834.
77. Wang, L. M.; Han, Y. F.; Tang, X. C. Huperzine A improves cognitive deficits caused by
chronic cerebral hypoperfusion in rats. Eur. J. Pharmacol., 2002, 398(1): 65-72.
78. Zhou, J.; Fu, Y.; Tang, X. C. Huperzine A protects rat pheochromocytoma cells against
oxygen-glucose deprivation. Neuroreport, 2001, 12: 2073-2077.
79. Yan, X. F.; Lu, W. H.; Lou, W. J.; Tang, X. C. Effects of huperzine A and B on skeletal
muscle and electroencephalogram. Acta Pharmacol. Sin., 1987, 8: 117-123.
80. Tu, Z. H.; Wu, M. Y. Mutagenicity and comutagenicity of three nootropics: huperzine A,
aniracetam and piracetam. New Drugs Clin. Remedies, 1990, 9: 65-68.
81. Zhao, H. W.; Li, X. Y. Ginkgolide A, B, and huperzine A inhibit nitric oxide production
from rat C6 and human BT325 glioma cells. Acta Pharmacol. Sin., 1999, 20(10):
941-943.
82. Li, Y.; Hu, G. Y. Huperzine A, a nootropic agent, inhibits fast transient potassium current
in rat dissociated hippocampal neurons. Neurosci. Lett., 2002, 324(1): 25-28.
83. Li, Y.; Hu, G. Y. Huperzine A inhibits the sustained potassium current in rat dissociated
hippocampal neurons. Neurosci. Lett., 2002, 329(2): 153-156.
84. Galeotti, N.; Ghelardini, C.; Mannelli, L. D.; Bartolini, A. Antinociceptive profile of the
natural cholinesterase inhibitor huperzine A. Drug Develop. Res., 2001, 54(1): 19-26.
85. Zhang, C. L. Therapeutic effects of huperzine A on the aged with memory impairment.
New Drugs Clin. Remedies, 1986, 5: 260-262.
86. Zhang, C. L.; Wang, G. Z. Effects of huperzine A tablet on memory. New Drugs Clin.
Remedies, 1990, 9: 339-341.
87. Xu, S. S.; Cai, Z. Y.; Qu, Z. W.; Yang, R. M.; Cai, Y. L.; Wang, G. Q.; Su, X. Q.; Zhong,
X. S.; Cheng, R. Y.; Xu, W. A.; Li, J. X.; Feng, B. Huperzine A in capsules and
Search WWH ::
Custom Search